Capecitabine

Product: AZ960

Identifier : DBSNPE000211
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • G > A (rs3918290 )

Allele Name : DPYD*2A
Genotype(s) : (A;A) / (A;G)
Type(s) : ADR Directly Studied
Groups : Non-functional DPYD
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 12738886

Capecitabine

Product: PNU-74654

Identifier : DBSNPE000212
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • A > C (rs55886062 )

Allele Name : DPYD*13
Genotype(s) : (C;C) / (A;C)
Type(s) : ADR Directly Studied
Groups : Non-functional DPYD
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 24077179

Capecitabine

Product: LY3177833

Identifier : DBSNPE000213
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • T > A (rs67376798 )

Allele Name : Not Available
Genotype(s) : (A;A) / (A;T)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 17461889

Capecitabine

Product: BAY1125976

Identifier : DBSNPE000214
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • G > A (rs1801158 )

Allele Name : DPYD*4
Genotype(s) : (G;G) / (A:G)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Associated with toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 17408599

Capecitabine

Product: AX20017

Identifier : DBSNPE000215
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • A > G (rs1801159 )

Allele Name : DPYD*5
Genotype(s) : (G;G) / (A;G)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Associated with toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 27010220

Capecitabine

Product: GSK189254A

Identifier : DBSNPE000216
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • G > A (rs1801160 )

Allele Name : DPYD*6
Genotype(s) : (A;A) / (A;G)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 9228663

Capecitabine

Product: Salermide

Identifier : DBSNPE000217
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • T > C (rs1801265 )

Allele Name : DPYD*9A
Genotype(s) : (C;C) / (C;T)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Associated with toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 1281719

Capecitabine

Product: CCT241534

Identifier : DBSNPE006020
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • G > A (rs3918290 )

Allele Name : DPYD*2A
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional DPYD
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 28099842

Capecitabine

Product: Istradefylline

Identifier : DBSNPE006021
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • A > C (rs55886062 )

Allele Name : DPYD*13
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional DPYD
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 16495926

Capecitabine

Product: Doramectin

Identifier : DBSNPE006022
Drug : DB01101 (Capecitabine)
Interacting Gene/Enzyme : Dihydropyrimidine dehydrogenase [NADP(+)]
Gene Name : DPYD
UniProt ID : Q12882
Defining Change(s) :

  • T > A (rs67376798 )

Allele Name : Not Available
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional DPYD
Description : Associated with 5-fluoracil toxicity
References :

  1. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. 2013 Dec;94(6):640-5. doi: 10.1038/clpt.2013.172. Epub 2013 Aug 29. [PubMed:23988873 ]

PMID: 8071941

By

Related Post